Cargando…
Impact of Treating Age-Related Macular Degeneration before Visual Function Is Impaired
Visual outcomes of age-related macular degeneration (AMD) have substantially improved via anti-vascular endothelial growth factor (anti-VEGF) therapy. However, the treatment effects vary among individuals. Medical charts of 104 eyes (104 patients) with AMD, treated with anti-VEGF drugs and followed...
Autores principales: | Aichi, Risa, Nagai, Norihiro, Ohkoshi, Kishiko, Ozawa, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573686/ https://www.ncbi.nlm.nih.gov/pubmed/36233594 http://dx.doi.org/10.3390/jcm11195726 |
Ejemplares similares
-
Arm-to-retina time predicts visual outcome of anti-vascular endothelial growth factor treatment for macular edema due to central retinal vein occlusion
por: Takei, Tatsuhiko, et al.
Publicado: (2022) -
Functional Visual Acuity in Age-Related Macular Degeneration
por: Tomita, Yohei, et al.
Publicado: (2016) -
Choriocapillaris Flow Imbalance in Fellow Eyes in Age-Related Macular Degeneration
por: Harada, Narumi, et al.
Publicado: (2022) -
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy
por: Okamoto, Tomohiro, et al.
Publicado: (2014) -
Maculopapular rash after intravitreal injection of an antivascular endothelial growth factor, aflibercept, for treating age-related macular degeneration: A case report
por: Nagai, Norihiro, et al.
Publicado: (2017)